Mar 3, 2020 10:00 am EST Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2020 Results Friday, March 6, 2020 at 8:30 AM E.T.
Feb 25, 2020 9:59 am EST Enzo Biochem Announces Preliminary Results of Voting at Annual Shareholder Meeting
Feb 19, 2020 8:30 am EST Enzo Biochem Reports Publication of Study Detailing Promising Activity of Drug Candidate SK1‑I in a Model of Lupus
Feb 11, 2020 8:30 am EST Enzo Biochem Announces Significant Milestone with Approval of Proprietary GenFlex Platform
Feb 7, 2020 8:00 am EST Enzo Disappointed in Harbert’s Lawsuit Aimed at Disenfranchising Shareholders
Jan 30, 2020 8:13 am EST Enzo Comments on Harbert’s Reaction to Providing Enzo Shareholders Additional Choices
Jan 28, 2020 5:45 pm EST Enzo Biochem Proposes to Increase Size of Board and Will Appoint Additional Highly Qualified, Diverse Independent Director in Near Future
Jan 13, 2020 8:00 am EST Enzo Biochem Responds to Series of Misleading and Inaccurate Statements from Activist Hedge Fund Harbert
